ORMP Annual Debt To Equity
0.31
+0.31+100.00%
01 December 2023
Summary:
As of January 22, 2025, ORMP annual debt to equity ratio is 0.31, with the most recent change of +0.31 (+100.00%) on December 1, 2023. ORMP annual debt to equity is now -42.59% below its all-time high of 0.54, reached on August 31, 2007.ORMP Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORMP Quarterly Debt To Equity
0.00
0.000.00%
01 September 2024
Summary:
As of January 22, 2025, ORMP quarterly debt to equity ratio is 0.00, unchanged on September 1, 2024. Over the past year, it has dropped by -0.32 (-100.00%). ORMP quarterly debt to equity is now -100.00% below its all-time high of 0.72, reached on February 29, 2008.ORMP Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORMP Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -100.0% |
| 3 y3 years | - | 0.0% |
| 5 y5 years | +100.0% | 0.0% |
ORMP Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | ||
| 5 y | 5-year | at high | -100.0% | ||
| alltime | all time | -42.6% | -100.0% | +100.0% |
Oramed Pharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 0.00(0.0%) |
| June 2024 | - | 0.00(-100.0%) |
| Mar 2024 | - | 0.20(-37.5%) |
| Dec 2023 | 0.31(>+9900.0%) | 0.32(-37.3%) |
| Sept 2023 | - | 0.51(>+9900.0%) |
| June 2023 | - | 0.00(0.0%) |
| Mar 2023 | - | 0.00(0.0%) |
| Dec 2022 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2022 | - | 0.00(0.0%) |
| June 2022 | - | 0.00(0.0%) |
| Mar 2022 | - | 0.00(0.0%) |
| Dec 2021 | 0.00(0.0%) | - |
| Nov 2021 | - | 0.00(0.0%) |
| Aug 2021 | 0.00(0.0%) | 0.00(0.0%) |
| May 2021 | - | 0.00(0.0%) |
| Feb 2021 | - | 0.00(0.0%) |
| Nov 2020 | - | 0.00(0.0%) |
| Aug 2020 | 0.00(0.0%) | 0.00(0.0%) |
| May 2020 | - | 0.00(0.0%) |
| Feb 2020 | - | 0.00(0.0%) |
| Nov 2019 | - | 0.00(0.0%) |
| Aug 2019 | 0.00(0.0%) | 0.00(0.0%) |
| May 2019 | - | 0.00(0.0%) |
| Feb 2019 | - | 0.00(0.0%) |
| Nov 2018 | - | 0.00(0.0%) |
| Aug 2018 | 0.00(0.0%) | 0.00(0.0%) |
| May 2018 | - | 0.00(0.0%) |
| Feb 2018 | - | 0.00(0.0%) |
| Nov 2017 | - | 0.00(0.0%) |
| Aug 2017 | 0.00(0.0%) | 0.00(0.0%) |
| May 2017 | - | 0.00(0.0%) |
| Feb 2017 | - | 0.00(0.0%) |
| Nov 2016 | - | 0.00(0.0%) |
| Aug 2016 | 0.00(0.0%) | 0.00(0.0%) |
| May 2016 | - | 0.00(0.0%) |
| Feb 2016 | - | 0.00(0.0%) |
| Nov 2015 | - | 0.00(0.0%) |
| Aug 2015 | 0.00 | 0.00(0.0%) |
| May 2015 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | 0.00(0.0%) |
| Nov 2014 | - | 0.00(0.0%) |
| Aug 2014 | 0.00(0.0%) | 0.00(0.0%) |
| May 2014 | - | 0.00(0.0%) |
| Feb 2014 | - | 0.00(0.0%) |
| Nov 2013 | - | 0.00(0.0%) |
| Aug 2013 | 0.00(0.0%) | 0.00(0.0%) |
| May 2013 | - | 0.00(0.0%) |
| Feb 2013 | - | 0.00(0.0%) |
| Nov 2012 | - | 0.00(0.0%) |
| Aug 2012 | 0.00(0.0%) | 0.00(0.0%) |
| May 2012 | - | 0.00(0.0%) |
| Feb 2012 | - | 0.00(0.0%) |
| Nov 2011 | - | 0.00(0.0%) |
| Aug 2011 | 0.00(0.0%) | 0.00(0.0%) |
| May 2011 | - | 0.00(0.0%) |
| Feb 2011 | - | 0.00(0.0%) |
| Nov 2010 | - | 0.00(0.0%) |
| Aug 2010 | 0.00(0.0%) | 0.00(0.0%) |
| May 2010 | - | 0.00(0.0%) |
| Feb 2010 | - | 0.00(0.0%) |
| Nov 2009 | - | 0.00(0.0%) |
| Aug 2009 | 0.00(0.0%) | 0.00(0.0%) |
| May 2009 | - | 0.00(0.0%) |
| Feb 2009 | - | 0.00(0.0%) |
| Nov 2008 | - | 0.00(0.0%) |
| Aug 2008 | 0.00(-100.0%) | 0.00(0.0%) |
| May 2008 | - | 0.00(-100.0%) |
| Feb 2008 | - | 0.72(+75.6%) |
| Nov 2007 | - | 0.41(-24.1%) |
| Aug 2007 | 0.54(>+9900.0%) | 0.54(-254.3%) |
| May 2007 | - | -0.35(+66.7%) |
| Feb 2007 | - | -0.21(<-9900.0%) |
| Nov 2006 | - | 0.00(0.0%) |
| Aug 2006 | 0.00(0.0%) | 0.00(0.0%) |
| May 2006 | - | 0.00(0.0%) |
| Feb 2006 | - | 0.00(0.0%) |
| Nov 2005 | - | 0.00 |
| Aug 2005 | 0.00 | - |
FAQ
- What is Oramed Pharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual debt to equity year-on-year change?
- What is Oramed Pharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly debt to equity year-on-year change?
What is Oramed Pharmaceuticals annual debt to equity ratio?
The current annual debt to equity of ORMP is 0.31
What is the all time high annual debt to equity for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual debt to equity ratio is 0.54
What is Oramed Pharmaceuticals annual debt to equity year-on-year change?
Over the past year, ORMP annual debt to equity ratio has changed by +0.31 (+100.00%)
What is Oramed Pharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of ORMP is 0.00
What is the all time high quarterly debt to equity for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly debt to equity ratio is 0.72
What is Oramed Pharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, ORMP quarterly debt to equity ratio has changed by -0.32 (-100.00%)